Revenue Cycle Management Leader Expands AI Adoption, Strengthens Industry Advocacy, and Builds for Next Phase of Innovation

XiFin, Inc., a leader in AI-enabled revenue cycle management (RCM), today reported strong operational growth across key segments in 2025, including 16.4% growth in its molecular diagnostics segment and 13.3% growth in its hospital segment. Volume flowing through XiFin® Empower RCM increased 21.1%, reflecting accelerating adoption of the company’s next-generation AI-powered revenue cycle solution. Building on this momentum, XiFin also announced the appointment of Sanjay Kumar as Chief Technology Officer to advance its AI innovation strategy in 2026.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260224897073/en/

XiFin welcomes Sanjay Kumar as Chief Technology Officer, bringing deep expertise to further enhance and scale the XiFin Empower ecosystem.

“Our performance in 2025 reflects more than strong results—it signals a structural shift toward intelligent, AI-driven revenue cycle infrastructure,” said Lâle White, Executive Chair and Chief Executive Officer of XiFin. “As healthcare organizations navigate mounting financial and operational complexity, we are scaling the XiFin Empower ecosystem to orchestrate automation, intelligence, and agentic capabilities across the revenue cycle. Bringing Sanjay onto our leadership team strengthens our ability to execute on that vision, advancing cloud-native innovation and positioning XiFin to help define the next era of healthcare financial operations.”

Broadening Technology Leadership to Scale AI Innovation and Advance Market Growth

Kumar brings more than two decades of experience scaling cloud-native and AI-driven platform modernization initiatives across healthcare and technology organizations. His expertise will be instrumental as XiFin rolls out advanced AI capabilities to support growth in emerging areas such as Medical Devices and Durable Medical Equipment (DME).

Most recently, as CTO of ResMed’s $800M Residential Care Software business, including MatrixCare, Brightree, and MEDIFOX DAN, Kumar led a multi-year transformation that unified fragmented product portfolios into a single cloud-native platform, embedded machine learning and generative AI into clinical and revenue cycle workflows, and drove institutionalized AI-assisted software development, resulting in sustained double-digit growth. His experience and expertise position XiFin to further enhance and scale the capabilities of the XiFin Empower ecosystem.

“XiFin’s momentum, combined with its commitment to AI‑powered innovation, makes this an extraordinary time to join the organization,” said Kumar. “The company’s technology foundation delivers measurable impact for clients, and there is enormous potential to extend that impact with next‑generation AI, agentic capabilities, and automation capabilities. I’m excited to help advance a technology vision that empowers healthcare organizations to achieve higher performance, greater efficiency, and stronger financial outcomes.”

XiFin Empower Gains Market Traction

The launch of the XiFin Empower ecosystem marked a major milestone in XiFin’s evolution toward an AI-driven enterprise infrastructure. Empower RCM, XiFin’s flagship solution, quickly gained traction among leading healthcare organizations, delivering measurable gains in automation, efficiency, and financial performance.

Partnering with XiFin, global laboratory leader Sonic Healthcare expanded its deployment across multiple divisions in 2025, while precision medicine innovator Caris Life Sciences publicly endorsed the impact of XiFin’s solution on revenue cycle productivity. These engagements reflect continued momentum for Empower RCM and its role in supporting complex revenue cycle operations.

The success of XiFin Empower also attracted notice from investors. In 2025, XiFin secured new capital investment led by Goldman Sachs External Investing Group, reinforcing investor confidence in the company’s AI-enabled growth strategy and long-term infrastructure vision.

Expanding Industry Engagement and Advocacy

As reimbursement models and interoperability policies continue to evolve, XiFin strengthened its industry engagement and advocacy efforts. The company joined the Pharmacy Interoperability and Clinical Services Alliance (PICSA), sharing insights and expertise while reinforcing its commitment to advancing interoperability standards and supporting pharmacists as clinical care providers.

Through PICSA and broader industry collaboration, XiFin is helping shape national, state, and industry frameworks that improve access to clinical services, strengthen data exchange, and enable diagnostics providers and pharmacies to play a more integrated role in patient care delivery.

Enhancing Governance and Strategic Oversight

XiFin also enhanced its Board of Directors with the addition of Jeff Margolis, a veteran healthcare IT executive with more than 35 years of leadership experience. Margolis previously served as CEO of multiple healthcare technology companies, including founding TriZetto, the industry’s first vertical SaaS platform, and currently serves as a Senior Advisor to Blackstone while supporting strategic investments and innovation across healthcare and information technology.

Accolades and Thought Leadership Reflect Continued Excellence

XiFin’s sustained performance and innovation were recognized across the healthcare industry:

• Named #1 in Black Book Market Research’s 2025 RCM Outsourcing Survey as the client-rated leader for cross-ancillary and outpatient laboratory services for the seventh consecutive year, and ranked #1 in outpatient radiology and diagnostic imaging RCM for the second year in a row
• Recognized in RXinsider’s 2026 Pharmacy500 as one of the top pharmacy supply chain businesses and associations that have made a significant impact on U.S. dispensing pharmacies over the past year
• Achieved HITRUST i1 Certification for key pharmacy-based cloud-hosted systems, reinforcing its commitment to cybersecurity and data protection
• Listed among Insights Care’s “Top 5 Revenue Cycle Management Companies of 2025,” with Chief Customer Officer Lee Ann Nichols featured on how XiFin “Helps healthcare providers turn financial complexity into competitive strength”
• Highlighted by Silicon Review as one of the “Global Best Companies to Watch in 2025”
• Introduced the inaugural 2025 Specialty Pharmacy Transformation Outlook, a new national survey that revealed opportunities for specialty pharmacy expansion, revenue growth, and technology adoption amid evolving industry dynamics
• Published the 2025 Payor Denial Impact Report, delivering one of the industry’s most comprehensive analyses of denial trends and financial pressures, equipping healthcare leaders with actionable intelligence to strengthen revenue cycle performance

Leadership Recognition

XiFin’s leadership team also received significant recognition:

• Multiple San Diego Business Journal honors, including CEO Lâle White named “SD 500 of the Most Influential People in San Diego,” with additional recognition for CFO Erik Sallee, Chief Legal and Compliance Officer Marty Barrack, Chief People Officer Niki Wallace, and SVP of Engineering & Analytics Jeff Carmichael
• Chief Legal and Compliance Officer Marty Barrack recognized by Insights Success as “A Forward-Thinking Leader in Legal Innovation and Risk Management”
• Sandra Greefkes, Ashley Keller, and Katie Williams, named as “2025 Top Women in Health, Wellness & Beauty” by Drug Store News

About XiFin

XiFin is a healthcare information technology company that empowers organizations to navigate an evolving and increasingly complex healthcare landscape. XiFin Empower orchestrates a variety of AI-enabled technologies to gain operational efficiencies and improve financial performance. Our comprehensive set of solutions—spanning revenue cycle management, clinical workflow enablement, laboratory information systems, and patient engagement—deliver THE POWER TO DO GOOD® so that healthcare organizations can do more good for more patients. Visit www.XiFin.com, follow XiFin on LinkedIn, or subscribe to the XiFin blog to learn more.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260224897073/en/

“Our performance in 2025 reflects more than strong results—it signals a structural shift toward intelligent, AI-driven revenue cycle infrastructure,” said Lâle White, Executive Chair and Chief Executive Officer of XiFin.